Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRenovaro Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Renovaro Biosciences Inc. Earnings Date And Information
Renovaro Biosciences Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Renovaro Biosciences Inc. has generated $-1 earnings per share over the last year ($-0.84 diluted earnings per share) and currently has a price-to-earnings ratio of -1.66. Renovaro Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based on prior year's report dates.
Renovaro Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/19/2025 | Q2 2024 | N/A | -$0.04 | N/A | N/A | $0 |
| 02/19/2025 | Q1 2024 | N/A | -$0.28 | N/A | $0 | $0 |
| 10/28/2024 | Q4 2023 | N/A | -$0.16 | N/A | $181,454 | $181,454 |
| 08/20/2024 | Q3 2023 | N/A | -$0.16 | N/A | N/A | $0 |
| 12/30/2023 | Q2 2023 | N/A | -$0.07 | N/A | N/A | $0 |
| 09/29/2023 | Q1 2023 | N/A | -$0.14 | N/A | N/A | $0 |
| 06/29/2023 | Q4 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 03/30/2023 | Q3 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 12/30/2022 | Q2 2022 | N/A | -$0.08 | N/A | N/A | $0 |
| 09/29/2022 | Q1 2022 | N/A | -$0.14 | N/A | N/A | $0 |
| 06/28/2022 | Q4 2021 | N/A | -$1.70 | N/A | N/A | $0 |
| 03/29/2022 | Q3 2021 | N/A | -$0.12 | N/A | N/A | $0 |
| 12/29/2021 | Q2 2021 | N/A | -$0.13 | N/A | N/A | $0 |
| 09/28/2021 | Q1 2021 | N/A | -$0.20 | N/A | N/A | $0 |
| 06/30/2021 | Q4 2020 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2021 | Q3 2020 | N/A | -$0.09 | N/A | N/A | $0 |
| 12/31/2020 | Q2 2020 | N/A | -$0.06 | N/A | N/A | $0 |
| 09/30/2020 | Q1 2020 | N/A | -$0.05 | N/A | N/A | $0 |
| 06/30/2020 | Q4 2019 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2020 | Q3 2019 | N/A | -$0.03 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Renovaro Biosciences Inc. Earnings: FAQ's
Renovaro Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based offlast year's report dates.
The conference call for Renovaro Biosciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Renovaro Biosciences Inc.'s latest earnings report can be read online.
Renovaro Biosciences Inc. (:RENB) has a recorded net income of $-80,650,171.Renovaro Biosciences Inc. has generated $-0.84 earnings per share over the last four quarters.
Renovaro Biosciences Inc. (:RENB) has a price-to-earnings ratio of -1.66 and price/earnings-to-growth ratio is -0.37.